N K Wenger
Affiliation: Emory University
Gongora M, Wenger N. Cardiovascular Complications of Pregnancy. Int J Mol Sci. 2015;16:23905-28 pubmed publisher
..The awareness of this relationship is growing in the medical community, especially among obstetricians and primary care physicians, who play a pivotal role in detecting these complications and assuring appropriate follow up. ..
Wenger N, Shaw L, Vaccarino V. Coronary heart disease in women: update 2008. Clin Pharmacol Ther. 2008;83:37-51 pubmed
..Although these women have more comorbidity and risk factors, other issues including biological differences, treatment differences, and psychosocial factors require management strategies tailored to the unique needs of women. ..
Wenger N. [Menopausal hormone therapy and cardiovascular disease]. Rev Esp Cardiol. 2006;59:1058-69 pubmed
Wenger N. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012;126:604-11 pubmed publisher
Wenger N. Clinical presentation of CAD and myocardial ischemia in women. J Nucl Cardiol. 2016;23:976-985 pubmed publisher
..Women, especially at younger age, whose acute myocardial infarction presentation is without chest pain have higher mortality rates than men without chest pain. ..
Varghese T, Hayek S, Shekiladze N, Schultz W, Wenger N. Psychosocial Risk Factors Related to Ischemic Heart Disease in Women. Curr Pharm Des. 2016;22:3853-70 pubmed
Wenger N, Doherty C, Gurwitz J, Hirsch G, Holmes H, Maurer M, et al
. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease. Drugs Aging. 2017;34:803-810 pubmed publisher
..This approach to aligning therapies with patient preferences is likely to promote patient satisfaction, to limit morbidity, and to favorably affect healthcare costs. ..